期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

索拉菲尼联合阿霉素治疗晚期胰腺癌的临床疗效 被引量：3

原文传递
导出
摘要 胰腺癌是一种临床上常见的恶性程度高、易转移、预后差的消化系统肿瘤。早期患者常出现腹痛、黄疸、消瘦、腰背疼痛和上腹饱胀等症状[1]。单纯放化疗对胰腺癌的敏感性较低,而分子靶向治疗药物的应用和发展为胰腺癌的治疗提供了新思路。有研究报道,索拉菲尼能抑制肝癌血管生成、细胞增殖,并可延长患者生存期,已被用作为晚期肝癌的首选用药[2-3]。但是,目前尚未见索拉菲尼治疗晚期胰腺癌的相关报道。
作者 郑圣明
机构地区 四川省宜宾县人民医院普外科
出处 《华南国防医学杂志》 CAS 2014年第8期824-825,共2页 Military Medical Journal of South China
关键词 索拉菲尼 阿霉素 晚期胰腺癌 临床疗效
分类号 R576 [医药卫生—消化系统]
  • 相关文献

参考文献10

  • 1史艳侠,徐瑞华,姜文奇,张力,林桐榆,李宇红,夏忠军,骆卉研,韩冰,王峰,何友兼,管忠震.吉西他滨联合奥沙利铂治疗晚期胰腺癌患者的疗效[J].癌症,2007,26(12):1381-1384. 被引量：11
  • 2Dal Lago L, DHondt V, Awada .&Selected combination therapy with sorafenib a review of clinical data and perspectives in a& vanced solid tumors[J].Oncologist, 2008, 13(8): 845-858.
  • 3Kelley RK, Venook AP. Sorafenib in hepatocellular carcinoma: separating the hype from the hope [J]. J Clin Oncol, 2008, 26 (36) : 5845-5848.
  • 4Therasse P, Arbuck SG, Eisenhauer EA,et al. New guidelines to evaluate the response to treatment in solid tumors.European Or- ganization for Research and Treatment of Cancer, National Canc- er Institute of the United States, National Cancer Instituteof Can- ada[J].J Natl Cancer Inst,2000,92(3):205-216.
  • 5Trotti A, Byhardt R, Stetz J,et a/.Common toxicity criteria: ver- sion 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy [J]. Int J Radiat Oncol Biol Phys,2000, 47(1 ) : 13-47.
  • 6Pang RW, Poon RT.From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now[J]. Oneology, 2007, 72(Suppl 1 ) :30-44.
  • 7Abou-Alfa GK, Schwartz L, Ricci S, et al. Phase study of sor afenibin patients with advanced hepatocellular carcinoma[J].J Clin Oncol, 2006,24 (26) : 4293-4300.
  • 8Llovet JM, Ricci S, Mazzaferro V. Sorafenibin advanced hepato cellular carcinoma[J].N Engl J Med,2008,359(4):378-390.
  • 9Chang YS,Adnane J, Trail PA,et al. Sorafenib ( BAY 43-9006) inhibits tumor growth and vascularization and induces tumor ap- optosis and hypoxia in RCC xenograft models [J]. Cancer Che- mother Pharmacol, 2007, 59( 5): 561-574.
  • 10Zhu AX. Development of sorafenib and other molecularly targeted a gents in hepatocellular carcinoma[J].Cancer,2008,112(2) :250-259.

二级参考文献11

  • 1周经兴,洪国斌,许凌云,许林锋,陈耀庭,江容坚,骆江红.选择性动脉插管持续灌注化疗治疗晚期胰腺癌的疗效分析[J].癌症,2004,23(12):1677-1680. 被引量：11
  • 2梁汉霖,王羽,谢德荣.关于晚期胰腺癌的Meta分析:吉西他滨联合化疗与吉西他滨单药[J].循证医学,2005,5(3):156-165. 被引量：28
  • 3郭双双,王羽,杨琼,谢德荣.吉西他滨联合5-FU或卡培他滨与吉西他滨单药治疗晚期胰腺癌对比的Meta分析[J].循证医学,2006,6(1):42-47. 被引量：8
  • 4Herrmann R, Bodoky G, Ruhstaller T, et al. Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase Ⅲ trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group [J]. J Clin Oncol, 2007, 25(16) : 2212-2217.
  • 5Heinemann V, Quietzsch D, Gieseler F, et al. Randomized phase Ⅲ trial of gemcitabine plus cisplatin with gemcitabine alone in advanced pancreatic carcinoma [J]. J Clin Oncol, 2006,24(24) : 3946-3952.
  • 6Louvet C, Labianca R, Hammel P, et al. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase Ⅲ trial [J]. J Clin Oncol, 2005, 23(15) :3509-3516.
  • 7Rothenberg M L. New development s in chemotherapy for patient's with advanced pancreatic cancer [J]. Oncology (Huntingt), 1996,10(9 Suppl) :S18-S22.
  • 8Alberts S R, Townley P M, Goldberg R M, et al. Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a north central cancer treatment group phase Ⅱ study [J]. Ann Oncol, 2003,14(4) :580-585.
  • 9Louver C, Andre T, Lledo G, et al. Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase Ⅱ study [J]. J Clin Oncol, 2002,20(16) : 1512-1518.
  • 10Demols A, Peeters M, Polus M, et al. Gemcitabine and oxaliplatine (GEMOX) in gemcitabine refractory advanced pancreatic cancer: a phase Ⅱ study [ J ]. Br J Cancer, 2006, 94(4) :481-485.

共引文献10

同被引文献33

引证文献3

二级引证文献5

华南国防医学杂志
2014年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
关于我们 | 版权声明 | 联系我们 | 帮助中心| 意见反馈
主办单位：上海市教育委员会
技术支持：重庆维普资讯有限公司
渝公网安备 50019002500403号
使用帮助 返回顶部